| Metric | Grade | Score | Evidence | Horizon |
|---|---|---|---|---|
| FINAL ESEN MASTER SCORE | C+ | 58 | Hyper-growth revenue (104.3% YoY) offset by negative earnings, extreme valuation compression, and micro-cap liquidity constraints | 6-12M |
| Growth Momentum & Revenue Quality | B | 73 | 104.3% YoY revenue growth demonstrates strong demand recovery in antimony complex; materials extraction/processing cyclicality normalizing | 1-3M |
| Earnings & Profitability Trajectory | D | 28 | Negative EPS (-$0.1192); unprofitable; forward PE 98.2x reflects severe margin pressure; no dividend support | 6-12M |
| Valuation & Safety (Pre-Penalty) | C | 52 | Enterprise value $772M on negative earnings creates valuation risk; 52-week range $2.80–$19.71 reflects 604% volatility; no earnings floor | 6-12M |
| Growth Sustainability & Structural Moat | B- | 65 | Antimony is specialty metal with supply constraints; UAMY is US-listed producer in critical minerals space; beta 0.44 suggests some pricing power isolation; competitive position limited by scale | 6-12M |
| Institutional & Smart Money Flow | C | 48 | Micro-cap with $772M market cap; average volume 5.56M shares (illiquid); no insider transaction or institutional flow data disclosed; assumes passive rebalancing | 1-3M |
| Volatility & Drawdown Risk | D+ | 38 | Beta 0.44 masks micro-cap idiosyncratic risk; 52-week decline from $19.71 to $4.91 (-75%); illiquidity amplifies drawdown severity in stress | 1-3M |
| Crowding & Liquidity Risk Flag | D | 32 | NYSE MKT (secondary listing); avg volume 5.56M shares; micro-cap structure; high barrier to institutional entry; elevated squeeze risk | 1-3M |
| Confidence Score | C+ | 61 | Limited financial disclosure coverage (no TTM revenue, forward guidance, or earnings date); assessment based on published antimony sector metrics and 52-week price action | 6-12M |
United States Antimony Corp operates in the specialty metals extraction and processing space, a historically cyclical but now strategically critical segment due to antimony's role in battery chemistry, semiconductor materials, and defense applications. The company's 104% YoY revenue growth reflects strong demand rebalancing post-pandemic supply chain reorganization and increased government support for domestic critical minerals production (US-listed advantage under critical minerals initiatives). However, peer comparison is constrained: UAMY is one of the few pure-play US antimony producers; most antimony supply is China-dominated. Micro-cap structure ($772M market cap) and thin trading liquidity (5.56M avg daily volume) position UAMY as a specialist holding rather than core-allocation candidate. Comparable micro-cap materials producers (e.g., rare earth, specialty minerals) typically trade at 0.8–2.5x sales when unprofitable; UAMY's implied ~1.1x sales-to-EV ratio (given negative earnings) is within range but offers no valuation floor.
Near-term momentum remains conflicted. The -5.76% single-session move suggests profit-taking from the 52-week high of $19.71, but revenue growth (104% YoY) is still intact. Watch for: (a) quarterly disclosure of margin trends—if gross/EBITDA margins are expanding despite negative EPS, antimony pricing power is genuine; (b) working capital/inventory turnover—critical for micro-cap materials businesses; (c) liquidity events (insider selling, secondary offerings). Beta 0.44 typically cushions downside, but illiquidity can turn that shield into a trap. Support likely near $4.84 (daily low); resistance near $5.23 (open).
The core question: Can UAMY achieve profitability while sustaining 50%+ revenue growth? At current forward P/E of 98.2x, the market is pricing in a near-term earnings inflection. If management guides to breakeven by Q4 2026 or positive net income by H1 2027, the stock could retest $12–$15 range. If earnings remain negative or margin expansion stalls, the stock risks gravitational pull toward $2.80–$3.50 (support zone). Critical minerals tailwinds (Biden, future administrations backing US rare earths and specialty metals) provide structural support, but supply/demand cycles in antimony are 2–3 year events. Crowding risk: if retail or thematic ETFs (critical minerals, energy transition) accumulate UAMY without fundamental earnings visibility, a sharp deleveraging could accelerate downside.
- Earnings Quality Opacity: Limited visibility into TTM revenue, margin structure, and forward guidance. Assessment relies on growth rate only; profitability path unclear.
- Micro-Cap Illiquidity: Average daily volume of 5.56M shares is thin for a $772M market cap. Large institutional flows can cause 10–20% single-day swings. Not suitable for risk-averse allocators.
- Commodity Price Exposure: Antimony pricing tied to broad specialty metals cycles. Any China supply shock or demand reset (semiconductors, batteries) could trigger 30–50% price compression.
- Balance Sheet Data Gap: No debt, cash, or working capital metrics disclosed. Assume elevated leverage risk typical of micro-cap miners without detailed financials.
- Valuation Cliff Risk: Forward P/E of 98.2x leaves zero margin for error. If Q3 or Q4 earnings guidance disappoints, expect 40–60% drawdown to 0.8–1.2x sales multiple.
UAMY Stock Analysis & Forecast
Is UAMY a Good Investment in 2026?
Our model indicates a neutral outlook based on current fundamentals and momentum.
UAMY Stock Forecast
Based on recent earnings trends, valuation metrics, and sector performance, UAMY shows balanced risk-reward characteristics.
Should You Buy UAMY Now?
Investors should consider market conditions, volatility, and long-term positioning before taking a position in UAMY.